TransWorldNews (press release)
... the rare disorder causes swelling in extremities, the intestinal tract or airways. Dyax stock jumped in after-hours trading, up $1.33 or 38 percent.
and more »
Tuesday, December 1, 2009
FDA Approval for Dyax's Genetic Disorder Drug, Kalbitor - TransWorldNews (press release)
TransWorldNews (press release)
... the rare disorder causes swelling in extremities, the intestinal tract or airways. Dyax stock jumped in after-hours trading, up $1.33 or 38 percent.
and more »
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment